Two elegant studies from the same group reported recently that GSK-3B overexpression in mice induces β-cell mass restriction and the development of diabetes [35] and that the genetic disruption of GSK-3B in β-cells results in increased β-cell mass in those transgenic mice [36]. The gene discussed is GSK3B; the disease is diabetes mellitus.